Anticancer drugs could make immunotherapies more effective

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers.

After Promising Universal Health Care, California Governor Must Reconsider Immigrant Coverage

SACRAMENTO, Calif. — Gov. Gavin Newsom didn’t expect to be reckoning with another health care crisis. In March, as President Donald Trump and congressional Republicans escalated a nationwide debate over

Drug company ads are easy to blame for misleading patients and raising costs, but research shows they do help patients get needed treatment

It’s a familiar experience for many Americans: You’re watching your favorite show and suddenly you’re ambushed by an ad for a drug whose name sounds like a Wi-Fi password, before